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Introduction
Non-ischemic dilated cardiomyopathy (DCM) is a major
cause for cardiovascular morbidity and premature mortal-
ity. Due to the variable clinical course, risk stratification is
of paramount importance in these patients to identify
those most likely to benefit from aggressive treatment
strategies. There is emerging evidence for the prognostic
significance of late gadolinium enhancement (LGE) in
patients with DCM.
Objective
The goal of this study was to further investigate the long-
term prognostic significance of LGE in a large cohort of
patients with DCM presenting to a tertiary referral center.
Methods
Contrast-enhanced cardiovascular magnetic resonance
(CE-CMR) was performed in 184 consecutive patients
with DCM on a 1.5 T clinical scanner. Significant coronary
artery disease had been ruled out in all patients. LV vol-
umes and mass were derived from SSFP cine images. Pres-
ence of LGE was determined by two independent
observers. Patients were followed for the primary end-
point of cardiac death and a composite endpoint of car-
diac death, hospitalization for decompensated heart
failure or appropriate ICD firing for a mean of 685 ± 30
days.
Results
LGE was detected in 72/184 patients (39%). Patients with
LGE showed a higher NYHA classification (2.2 ± 0.09 vs.
1.9 ± 0.07, p = 0.02) and were more often on oral diuretics
(42/72 pts. vs. 45/112 pts., p = 0.02). Presence of LGE was
associated with a lower EF (31.6 ± 1.7% vs. 40.4 ± 1.2%,
p < 0.001), higher EDV (288.7 ± 12.2 ml vs. 233.6 ml, p <
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Event-free survival according to presence of LGEFigure 1
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0.001) and a more pronounced increase of LV mass/BSA
(81.9 ± 2.9 g/m2 vs. 70 ± 2.2 g/m2, p < 0.001). There was
a trend towards a higher incidence of the primary end-
point in patients with LGE (4/72 vs. 1/112, p = 0.06). The
rate of the composite endpoint was significantly associ-
ated with the presence of LGE (15/72 vs. 6/112, p = 0.002,
Figure 1). When entered into multivariate Cox regression
analysis, LGE did not retain an independent predictive
value (Table 1).
Table 1: Predictors of the composite endpoint by Cox 
regression
HR (95% CI) P
Univariate
EF (%) 0.94 (0.91-0.98) < 0.001
LGE (y/n) 3.5 (1.4-9) 0.01
Age (yrs) 1.06 (1.02-1.09) 0.001
Male gender 1.29 (0.43-3.83) 0.65
NYHA class 1.84 (0.98-3.46) 0.06
Multivariate model
Age (yrs) 1.04 (1.02-1.09) 0.001
EF (%) 0.94 (0.91-0.97) 0.001Page 2 of 2
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